§ Mr. BurstowTo ask the Secretary of State for Health what representations he has received from Johnson and Johnson on the risk of stroke in atypical antipsychotics used on patients with dementia. [162424]
§ Dr. LadymanThe marketing authorisation holder for risperidone, Janssen Cilag UK Ltd., is a wholly owned subsidiary of the United States company Johnson and Johnson. Aside from the data and interpretation received from Janssen Cilag and their corresponding applications to vary the UK Marketing Authorisations in respect of the risk of stroke associated with use of risperidone in patients with dementia, no representations have been received from the company.